Sempra heads into the back half of June with short sellers adding positions at a notable pace while the broader analyst community maintains a constructive but slightly trimmed outlook.
The most interesting tension this week is the divergence between a stock that closed up 2.1% on Tuesday at $90.87 and a short interest position that has grown 15% over the past month to roughly 1.59% of free float — a level still too small to alarm, but a direction of travel worth tracking.
Short interest has climbed steadily since early May, rising from around 8.7 million shares to 10.4 million, with the sharpest jump — an 11% single-day increase — logged on June 9. The rebuild is gradual rather than aggressive: borrowing costs remain extremely cheap at just 0.50%, and availability in the lending pool is as loose as it gets, effectively uncapped at the high-availability ceiling. There is no squeeze pressure, no lending tension, and nothing in the borrow market to suggest this short position carries any forced-covering risk. The ORTEX short score, at 31.8, reflects that — it has crept up fractionally over the past week but sits in a clearly non-alarming range. Options positioning reinforces the relaxed tone: the put/call ratio of 0.28 is only a half standard deviation above its 20-day average of 0.25, well below the prior-year high of 1.07, and closer to the bullish end of its historical range. Overall, the positioning picture looks mildly cautious rather than meaningfully bearish.
The Street remains broadly constructive on Sempra, though recent analyst activity has been a story of modest target trimming rather than any change of heart on direction. Multiple firms — including Truist, BMO, and Morgan Stanley — have nudged price targets down in recent weeks, generally by $2–$4, while maintaining Buy or Outperform ratings. Those trims land the consensus mean target at $103.50, implying about 14% upside from current levels. Wells Fargo is the outlier, holding a $115 target with an Overweight rating set in late March. The bull case centres on Oncor's regulated Texas footprint, improved regulatory visibility around California utility standards, and the long-run infrastructure buildout thesis. Bears flag the declining profitability trend at Sempra Infrastructure, LNG execution risk, and rising net interest expense at the parent level. On valuation, the P/E multiple at 17.1x and EV/EBITDA near 15.6x have both eased slightly over 30 days, consistent with the modest price dip over the month. The dividend score ranks in the 94th percentile — a reminder that income-oriented holders provide a structural floor to the register.
On institutional ownership, the top of the register is dominated by index and passive allocators. BlackRock holds 9.2% of shares, with State Street and Vanguard entities accounting for another 16% combined. JP Morgan Asset Management added nearly 4.6 million shares in its most recent filing — a notable incremental position — while FMR (Fidelity) added 1.3 million. The insider picture over the past 90 days shows a modest net positive in shares, but the recent trade log skews toward small routine sells by directors and the Chief Legal Counsel, all with low significance scores. None of the recent insider activity tells a particularly strong directional story.
Sempra's most recent earnings print, from early May, saw the stock fall roughly 2.3% the following day and drift a further 0.9% over the subsequent week — a soft but contained reaction. The next result is scheduled for August 4. Between now and then, the variables worth watching are any regulatory developments in California affecting the utility standards that underpinned the recent price recovery, and whether the short rebuild continues at its current pace or stalls now that the stock has clawed back some of its May losses relative to peers like CMS (+1.1% on the week) and WEC (+2.6%).
See the live data behind this article on ORTEX.
Open SRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
